Regenerative
Half-life: Research estimates suggest relatively rapid clearance; TB-500 fragment has ~2-3 hour half-life
Thymosin Beta-4
Thymosin Beta-4 (Tβ4)
Thymosin Beta-4 is one of the most abundant proteins in human cells, and for good reason—it's a master regulator of healing. This 43-amino acid protein was originally isolated from the thymus but is actually produced throughout the body wherever tissue repair is needed. Its primary function is managing actin, the protein that forms cellular scaffolding and enables cells to move. By sequestering G-actin (the building block form), Thymosin Beta-4 controls how and when cells reorganize their structure for migration, division, and wound closure. Beyond actin regulation, it reduces inflammation, promotes blood vessel formation (angiogenesis), protects cells from death signals, and appears to activate stem cells. The research peptide TB-500 is derived from Thymosin Beta-4's active region, but the full molecule contains additional sequences that may contribute to its regenerative effects. In clinical trials, Thymosin Beta-4 has shown promise for wound healing, corneal injuries, and cardiac repair after heart attacks. It represents an emerging understanding that the body's own healing factors might be enhanced therapeutically.
Table of Contents
What is Thymosin Beta-4?
Thymosin Beta-4 is one of the most abundant proteins in human cells, and for good reason—it's a master regulator of healing. This 43-amino acid protein was originally isolated from the thymus but is actually produced throughout the body wherever tissue repair is needed. Its primary function is managing actin, the protein that forms cellular scaffolding and enables cells to move. By sequestering G-actin (the building block form), Thymosin Beta-4 controls how and when cells reorganize their structure for migration, division, and wound closure. Beyond actin regulation, it reduces inflammation, promotes blood vessel formation (angiogenesis), protects cells from death signals, and appears to activate stem cells. The research peptide TB-500 is derived from Thymosin Beta-4's active region, but the full molecule contains additional sequences that may contribute to its regenerative effects. In clinical trials, Thymosin Beta-4 has shown promise for wound healing, corneal injuries, and cardiac repair after heart attacks. It represents an emerging understanding that the body's own healing factors might be enhanced therapeutically.
Research Benefits
Accelerates wound healing
Reduces inflammation
Promotes cell migration and tissue repair
Supports angiogenesis (new blood vessel formation)
Protects tissues from hypoxic damage
May improve cardiac function post-injury
Promotes hair follicle stem cell activity
Regulates extracellular matrix remodeling
Research Applications
Wound healing and tissue repair
Active research area with published studies
Cardiac regeneration post-MI
Active research area with published studies
Corneal healing and dry eye
Active research area with published studies
Muscle injury recovery
Active research area with published studies
Dermal wound closure
Active research area with published studies
Neuroregeneration
Active research area with published studies
Hair growth stimulation
Active research area with published studies
Anti-fibrotic applications
Active research area with published studies